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Abstract 
Background: One of the most important research subjects of metabolic engineering is pursuing a balanced 
metabolic pathway, which is the basis of an efficient cell factory. In this work, we dedicated to develop a simple and 
efficient technique to modulate expression of multiple genes simultaneously, and select for the optimal regulation 
pattern.
Results: A Type IIs restriction based combinatory modulation (TRCM) technique was designed and established in the 
research. With this technique, a plasmid library containing variably regulated mvaE, mvaS, mvaK1, mvaD and mvaK2 
of the mevalonate (MVA) pathway were obtained and transformed into E. coli DXS37-IDI46 to obtain a β-carotene 
producer library. The ratio of successfully assembled plasmids was determined to be 35%, which was increased to 
100% when color based pre-screening was applied. Representative strains were sequenced to contain diverse RBSs as 
designed to regulate expression of MVA pathway genes. A relatively balanced MVA pathway was achieved in E. coli cell 
factory to increase the β-carotene yield by two fold. Furthermore, the approximate regulation pattern of this optimal 
MVA pathway was illustrated.
Conclusions: A TRCM technique for metabolic pathway optimization was designed and established in this research, 
which can be applied to various applications in terms of metabolic pathway regulation and optimization.
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Background
As the development of Synthetic Biology and Meta-
bolic Engineering, various microbial cell factories have 
been developed for producing value-added chemical 
compounds. However, engineering of cell metabolism 
often disturbs the metabolic network,triggers energetic 
and objective inefficiency inside the cell, and impedes 
cell metabolism [1]. Hence, one of the most important 
research subjects of metabolic engineering is pursuing 
the balanced metabolic network and pathways. Tech-
niques have been developed to analyze metabolic path-
ways, including genome-scale models and C13-metabolic 
flux analysis. And there have been strategies developed 
to relieve the metabolic burden, such as enhancing res-
piration, co-utilizing nutrient resources, decoupling cell 
growth with production phases, and dynamic regula-
tory systems [1]. As for a specific metabolic pathway, 
gene expression level is the key effector of the path-
way efficiency [2]. Lower expression of genes decreases 
metabolic pathway flux, while overexpressed genes may 
over-consume building blocks and cause cells metabolic 
burden [3]. Furthermore, imbalanced pathway may cause 
accumulation of pathway intermediates, some of which 
may even be toxic and jeopardize cell growth [4].
Due to the complexity of metabolic network in organ-
isms and difficulty to precisely control expression of 
certain gene, it is almost impossible to rationally design 
and construct an optimized metabolic pathway. In most 
metabolic engineering projects, one common way was to 
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modulate gene expression one by one [5]. With this strat-
egy, the possibility to achieve an optimized regulation 
pattern is very low. A better solution was to analyze all 
possible expression levels of pathway genes in a combi-
natorial fashion. With this strategy, Yin et al. constructed 
a plasmid library containing the possible combinations 
of gene regulation patterns [6]. A similar strategy was 
employed by Xu et al. to optimize fatty acid pathway. Plas-
mids of various copy numbers were used to carry expres-
sion genes for the first round of optimization, which was 
followed by fine tuning expression with four RBS ele-
ments [7]. However, in their work, regulatory parts were 
limited and the plasmids were exhaustively constructed 
one by one, which limited the experiment outcome and 
made the process laborious. The same group also estab-
lished a BioBrick based method with specially designed 
restriction adapters. Genes with regulatory elements 
could be iteratively integrated into the ePathBrick vectors 
to create a diversified expression library [8]. Similarly, 
Zelcbuch et  al. created a plasmid library construction 
method to “span high-dimensional expression space” 
[9]. In their methods, the libraries were constructed with 
multiple rounds of plasmid construction, which made the 
practice very time consuming. In the work of Lee et al., a 
combinatorial library was established by Gibson assem-
bly based method in one reaction [10, 11]. However, only 
five regulatory parts were employed, which decreased 
the diversity of the combinatorial library. Based on the 
extensive researches and great progress achieved by fel-
low researchers in this subject, we were able to develop a 
convenient method for constructing complex combinato-
rial expression library, which was aimed for optimizing a 
metabolic pathway with maximal outcome and minimal 
lab hours.
β-carotene, one kind of isoprenoids, is one of the 
strongest antioxidant in nature [12], and has tremendous 
potential in healthcare and pharmaceutical industries 
[13, 14]. Isoprenoids are all derived from two five-car-
bon building blocks, isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP), which are syn-
thesized either by the mevalonate (MVA) pathway in 
eukaryotes, archaea, and some bacteria or 2-C-methyl-d-
erythritol-4-phosphate (MEP) pathway in other prokar-
yotes and plastids in plants (Fig.  1) [13–15]. In MVA 
pathway, two acetyl-CoA are condensed into one atetoa-
cetyl-CoA, which is then reduced into 3-hydroxy-3-me-
thyl-glutaryl-coenzyme A (HMG-CoA). The CoA group 
is released from HMG-CoA to form MVA, which is 
phosphorylated into mevalonate-5-phosphate, and then 
mevalonate-5-diphosphate. This compound is coverted 
into IPP, the common precusor of isoprenoids (Fig.  1). 
The heterologous MVA pathways have been introduced 
into E. coli to improve precursor supply of IPP and 
DMAPP [16–20]. Isoprenoid production was improved 
by employment of the bottom portion of MVA pathway 
derived from Streptococcus pneumoniae and supplemen-
tation of MVA in culture [18, 20]. Lycopene production 
of E. coli with only native MEP pathway was increased 
twofold with introduction of the whole MVA path-
way from Streptomyces sp. CL190 [19]. However, over-
expression of mevalonate pathway genes was reported 
to inhibit cell growth. Pitera et al. found that accumula-
tion of MVA pathway intermediate HMG-CoA inhibited 
cell growth, which was caused by overexpression of atoB, 
mvaS and hmg1 [4]. Mevalonate kinase (MK), encoded 
by erg12, was identified as another rate-limiting enzyme 
when MVA pathway was adopted for amorphadiene pro-
duction in E. coli [21]. Thus, the MVA pathway has to be 
expressed in an optimized and balanced status to benefit 
isoprenoid cell factories, otherwise an unbalanced MVA 
pathway would impede the growth and production. In 
this work, an MVA pathway optimized by combinatorial 
expression library technique was to be introduced into 
MEP pathway dependent E. coli cell factory for improv-
ing β-carotene production (Fig. 2).
Methods
Strains, medium and growth conditions
Strains used in this study are listed in Table  1. During 
strain construction, cultures were grown aerobically at 
30 or 37 °C in Luria broth (per liter: 10 g Difco tryptone, 
5  g Difco yeast extract and 5  g NaCl) and fermentation 
medium (per liter: 10 g Difco yeast extract, 15 g glycerol, 
10.5 g K2HPO4.3H2O, 6 g (NH4)2HPO4, 5 g MgSO4·7H2O, 
1.84  g citric acid monohydrate and 10  mL microele-
ments solution; Microelements solution per liter: 10  g 
FeSO4·7H2O, 5.25  g ZnSO4·7H2O, 3.0  g CuSO4·5H2O, 
0.5 g MnSO4·4H2O, 0.23 g Na2B4O7·10H2O, 2.0 g CaCl2 
and 0.1  g (NH4)6Mo7O24). For β-carotene production, 
single colonies were picked from LB plate and inocu-
lated into 15 × 100 mm tubes containing 4 mL LB with 
or without 34 mg/L chloramphenicol, and grown at 30 °C 
and 250  rpm overnight. Seed culture was subsequently 
inoculated into 100  ml flask containing 10  mL fermen-
tation medium at an initial OD600 of 0.05, with or with-
out 34  mg/L chloramphenicol, and grown at 30  °C and 
250 rpm. After growth for 24 h, cells were collected for 
measurement of β-carotene production.
Genes, vector and primers
MVA pathway genes mvaE, mvaS, mvaK1, mvaD, and 
mvaK2 were amplified from genomic DNA of Enterococ-
cus faecalis CGMCC No.1.2135 using primer set Ga2-
R1-EfmvaE-F/Ga2-R1-EfmvaE-R, Ga3-R1-EfmvaS-F/
Ga3-R1-EfmvaS-R, and from genomic DNA of Strep-
tococcus pneumoniae CGMCC No.1.8722 using primer 
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set Ga46-R1-SpmvaK1-F/Ga46-R1-SpmvaK1-R, Ga7-
R1-SpmvaD-F/Ga7-R1-SpmvaD-R, and Ga8-R1-Spm-
vaK2-F/Ga8-R1-SpmvaK2-R respectively (Additional 
file  1: Table S1). The DNA fragments used for assem-
bly were gel purified and designated as Ga2-mvaE, 
Ga3-mvaS, Ga46-mvaK1, Ga7-mvaD and Ga8-mvaK2 
(Fig.  1b). Vector Fragment Ga91-184A was amplified 
from pACYC184-PgadA-RFP, and subjected to DpnI 
digestion (10 U, 16  h, 37  °C) and gel purification. PCR 
was performed with PrimeSTAR® HS DNA Polymer-
ase (Takara) with primers purchased from GENEWIZ 
(Suzhou, China). All assembly primers were designed 
with optimized linkers for Type IIs restriction enzyme 
based assembly, in which forward primers for amplifica-
tion of genes were embedded with an RBS library at 5′ 
ends. Primers used in this study are summarized in Addi-
tional file 1: Table S1.
Construction of mva operon variants using TRCM
DNA fragments were assembled by Golden Gate DNA 
assembly method [22, 23]. 100 nanogram vector fragment 
Ga91-184A and equimolar amount of PCR amplified 
genes Ga2-mvaE, Ga3-mvaS, Ga46-mvaK1, Ga7-mvaD 
and Ga8-mvaK2 were mixed in 20 μL Golden Gate reac-
tion solution with 1 μL BsaI-HF, 1 μL T4 ligase (New Eng-
land Biolabs, Ipswich, MA) and 1× T4 ligase buffer. The 
reaction was carried out in a thermocycler using the fol-
lowing program: 37 °C for 5 min, 37 °C for 5 min (step 2), 
16 °C for 10 min (step 3), step 2 and 3 for 20 cycles, 16 °C 
for 20 min, 37 °C for 30 min, 75 °C for 6 min, and 4 °C for 
hold. After PCR, 0.5 μL plasmid-safe nuclease (Epicenter), 
and 1 μL of 25 mM ATP was added to the reaction, which 
was incubated at 37 °C for 15 min. 1.5 μL of the resultant 
reaction solution were transformed into 80 μL competent 






































































Fig. 1 Illustration of β-carotene synthesis pathway in E. coli DXS37-IDI46 (pACYC184-AL-mva). This route involved β-carotene synthesis module, 
MEP module and MVA module. MVA Genes modulated with TRCM were underlined. G-3-P glyceraldehyde-3-phosphate, DXP 1-deoxy-d-xylulose-
5-phosphate, MEP 2C-methyl-d-erythritol-4-phosphate, CDP-ME 4-diphospho-cytidyl-2C-methyl-d-erythritol, CDP-MEP 4-diphosphocytidyl-
2C-methyl-d-erythritol-2-phosphate, MEC 2C-methyl-d-erythritol-2,4-cyclodiphosphate, HMBPP 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate, 
HMG-CoA 3-hydroxy-3-methyl-glutaryl-coenzyme A, MVA mevalonate, MVA-5-P mevalonate-5-phosphate, MVA-5-PP mevalonate-5-diphosphate, IPP 
isopentenyl diphosphate, DMAPP dimethylallyl diphosphate, GPP geranyl diphosphate, FPP farnesyl diphosphate, GGPP geranylgeranyl diphosphate
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In order to determine whether the MVA pathway genes 
were successfully incorporated into vector backbone, 
recombinant clones were subjected to colony PCR anal-
ysis. PCR primers were designed to amplify the region 
from mvaE (the first gene on plasmid) to mvaK2 (the last 
gene on plasmid) by primers fE-JF and pK2-JR (Addi-
tional file  1: Table S1), which had a product size of 3.8 
Kbp. A master mix with 1× Es Taq MasterMix (CWBio, 
Peking, China) and 0.4  μM forward and reverse primer 
(Additional file  1: Table S1) was prepared, and 20  μL 
master mix was dispensed into each PCR tubes. Colonies 
were directly transferred from LB agar plates into the 
PCR tubes with sterile toothpicks. The PCR cycling was 
started with an initial denaturation temperature at 94 °C 
for 10 min, followed by 30 cycles (94 °C, 30 s; 61 °C, 30 s; 
and 72 °C, 2 min) and one fill-up cycle (72 °C, 2 min). The 
PCR products were analyzed on agarose–TAE gels.
Measurement of β‑carotene titer
Production of β-carotene was quantified by measuring 
absorption of acetone-extracted β-carotene at 453 nm as 
previously reported [24]. A standard curve was obtained 
by measuring OD453 of β-carotene standard samples (Cat. 
No. C4582, Sigma, USA) with varied concentrations using 
a Shimadzu UV-2550 spectrophotometer (Shimadzu, 
Kyoto, Japan). The results represented the mean ± stand-
ard deviation (S.D.) of three independent experiments. 
Dry cell weight (DCW) was calculated based on optical 
density at 600 nm (1 OD600 = 323 mg DCW).
Calculation of MVA pathway genes RBS strength of strains 
from TRCM libraries
RBS sequences of mvaE, mvaS, mvaK1, mvaD, and mvaK2 
in representative strains were obtained by PCR and DNA 
sequencing. Their theoretical RBS strength characterized 
Fig. 2 Modulation and optimization of MVA pathway with TRCM technique. a Primer design for obtaining assembly parts containing degener-
ate RBS sequences. Primers for amplification of MVA genes were embedded with BsaI recognition site, optimized four bp linkers, and random RBS 
sequence AGGAGRNNNNNN. b TRCM DNA parts for assembly. One ready-made vector part was used to assemble with five library parts. c Combina-
tory expression library of MVA pathway. The plasmid library contained all five genes regulated with degenerate RBSs in various combinations
Table 1 Strains and plasmids in this study
Strains/plasmids Relevant characteristics Source/notes
Strains
 E. coli DH5α F−endA1thi-1 recA1 relA1 
gyrA96deoRΦ80dlacΔ(lacZ) 






 CGMCC 1.2135 Enterococcus faecalis wild-type CGMCC
 CGMCC 1.8722 Streptococcus Pneumoniae 
wild-type
CGMCC







E. coli expression vector derived 
from pACYC184, promoter of 
gadA, RFP, cat
Laboratory stock
 pACYC184-AL-mva plasmid library of combinatori-
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by the value of translation initiation rate was calculated 
with the RBS Calculator [25, 26]. The RBS sequence 
diversity of the combinatory library was analyzed with 
the Weblogo software [27].
Results and discussions
Design of a Type IIs restriction based combinatory 
modulation technique (TRCM) for metabolic pathway 
optimization
With the purpose of developing a simple technique to 
modulate and optimize expression of multiple genes 
simultaneously, we designed a Type IIs restriction based 
combinatory modulation technique (TRCM) for meta-
bolic pathway optimization as illustrated in Fig. 2. Variably 
regulated genes were obtained by PCR amplification with 
extended primers, in which degenerate RBS nucleotides 
were embedded at the 5′ ends. Specifically designed link-
ers for Type IIs restriction enzymes were also imbedded in 
the primers to ensure the assembly pattern and efficiency.
Type IIs restriction based Golden Gate [23] was 
employed as DNA assembly method in this work, which 
has several advantages. First, there is no PCR reaction 
involved in the assembling process, which reduces the 
possibility of mutation compared with other PCR based 
assembly methods such as Gibson and CPEC [10]; sec-
ond, the ligase facilitated irreversible ligation greatly 
improves assembly efficiency compared with homolo-
gous arm based method [23]. With this method, gene 
parts of a pathway were assembled with a vector part to 
form an expression plasmid. Since each gene part was 
constructed to carry a collection of regulatory parts, 
a combinatory plasmid library with variably regulated 
pathway genes was created, which was subsequently 
transformed into dedicated host to be screened and 
selected for strains carrying optimized pathways.
This technique was designed with the modularized 
strategy to be as simple as possible. The vector part was 
ready-made for all reactions, providing a stable plasmid 
backbone. By incorporation of fixed linkers and regula-
tory elements in primers for amplification of genes, the 
only variable parts of this method were the actual PCR 
primer sequences of pathway genes (Fig. 2a).
Development and application of TRCM for MVA pathway 
optimization
Our lab has constructed a few E. coli β-carotene produc-
ers, such as DXS37-IDI46 and CAR001, by modulating 
several key genes of the MEP pathway module, the pen-
tose phosphate pathway (PPP) module, the ATP module 
and the tricarboxylic acid cycle (TCA) module [24]. In 
this work, a heterologous MVA pathway optimized with 
TRCM technique was introduced into DXS37-IDI46 for 
further improving its β-carotene production (Fig. 2).
Since MVA pathway upstream genes mvaS, mvaE from 
Enterococcus faecalis and downstream genes mvaK1, 
mvaK2, mvaD from Streptococcus pneumoniae were 
reported to be successfully expressed in E. coli, they were 
selected to be used in this research [17]. As designed with 
the TRCM technique, primers for PCR amplification of 
vector and MVA genes were embedded with BsaI rec-
ognition sites GGTCTC and specific four bp linkers, in 
order to be assembled in sequence. These linkers were 
rationally designed and experimentally tested to enable 
efficient assembly of DNA parts regardless of condition 
change (Fig. 2a).
To create a library of differently regulated genes, the 
RBS sequences of each gene were degenerated. For this 
purpose, forward primers of MVA genes Ga2-R1-Efm-
vaE-F, Ga3-R1-EfmvaS-F, Ga46-R1-SpmvaK1-F, Ga7-
R1-SpmvaD-F and Ga8-R1-SpmvaK2-F were embedded 
with the random RBS sequence AGGAGRNNNNNN 
behind the 4 bp linkers. The starting code ATG of each 
gene was located behind the six Ns, which was also the 
starting point of actual PCR primers (Fig. 1a).
Gene parts, which carried front and back linkers for 
assembly in sequence, were obtained with PCR amplifi-
cation. In Golden Gate assembly reaction, PCR amplified 
mvaS, mvaE, mvaK1, mvaK2 and mvaD parts were mixed 
with the ready-made vector part Ga91–184A (Fig.  1b). 
After reaction, a plasmid library was created, which had 
differentially regulated MVA genes in various combina-
tions. Theoretically, all patterns of differently expressed 
MVA pathway could be obtained in such a library 
(Fig. 1c). With this simple method, we achieved the goal 
of spanning high-dimensional expression space [9].
β‑carotene production was improved with TRCM 
optimized MVA pathway
To select for the optimally expressed MVA pathways, 
Golden Gate reaction solution containing plasmid 
library was transformed into the β-carotene producer 
strain DXS37–IDI46 (Table  1). After electroporation, 
transformed cells were plated on solid LB with 34 mg/L 
chloramphenicol to select for plasmid bearing trans-
formants. Orange colored colonies with various inten-
sity appeared on the plates as expected after incubation 
overnight (Fig. 3a), which indicated their different capac-
ity of β-carotene production. Colonies were randomly 
picked and analyzed by colony PCR to determine the 
ratio of successful assembly, for which PCR primers were 
designed to amplify the region from mvaE to mvaK2 with 
primers fE-JF and pK2-JR (Additional file  1: Table S1), 
with an expected product size of 3.8 Kbp. As illustrated in 
Fig. 3a of TAE gel electrophoresis, 22 of 63 screened colo-
nies had PCR bands of the correct size, which indicated a 
35% successful assembly ratio of the synthetic operon. To 
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determine this ratio of strains with increased β-carotene 
production, transformants were picked and evenly re-
streaked on fresh chloramphenicol LB plates, which was 
to improve the reliability of color based β-carotene pro-
duction screening (Fig. 3b). Colonies with deeper orange 
color were selected for PCR analysis. The gel electropho-
resis (Fig. 3b) indicated a positive ratio of 100%, since all 
24 strains gave the correct PCR products. The results 
indicated a decent assembly ratio of 35% was achieved by 
TRCM technique with modulation of five genes simulta-
neously, and a higher successful ratio could be achieved 
with a simple color based pre-screening process.
To select strains with significantly improved β-carotene 
producing capacity, colonies with deeper color were cul-
tured aerobically, and the β-carotene titer was measured. 
Ten representative strains ALV104, ALV131, ALV100, 
ALV108, ALV20, ALV63, ALV25, ALV133, ALV23, and 
ALV145 were determined to have improved β-carotene 
production to various extent in comparison with DXS37-
IDI46, as illustrated in Fig.  4. Strain ALV145 had the 
highest yield of 11.17  ±  0.82  mg/g, which was a 96.0% 
increase compared with the parent strain DXS37-IDI46. 
The significant improvement indicated that an efficient 
cell factory with optimized metabolic pathway could be 
obtained by the simple TRCM technique.
A combinatorial expression library with five genes 
regulated by diverse RBSs was obtained with TRCM 
technique
To analyze the degenerated RBS sequences regulating 
MVA gene, PCR was used to amplify regions containing 
the RBS sequences of MVA operon genes in representa-
tive strains. The PCR products were sequenced subse-
quently to obtain the RBS sequence information, which 
Fig. 3 Determination of successfully assembled combinatory expression library pACYC184-AL-mva in host DXS37-IDI46. A 35% successful assembly 
ratio was determined by PCR analysis of randomly selected colonies, and a 100% assembly ratio was achieved with a color based pre-screening 
process. a DXS37-IDI46 transformed with TRCM assembly reaction solution after overnight incubation on LB plate. Colonies were randomly picked 
and analyzed by colony PCR to determine ratio of successfully assembled pACYC184-AL-mva. M marker, 1–21 colonies picked from LB plate.  
b Colonies from original plates were picked and evenly re-streaked on fresh chloramphenicol LB plates, then were validated by colony PCR. M 
marker, 1–24 colonies picked from the plate
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was summarized in Table  2. As designed, a combinato-
rial expression library with the five MVA genes regu-
lated by diverse RBSs was obtained. For each strain, RBSs 
of the five genes were all different; and for each gene, all 
ten RBSs were not same either. Diversity of the degener-
ate RBS sequence RNNNNNN from combinatory library 
was further analyzed with the Weblogo software [27]. A 
good but not great diversity was obtained for each of the 
five MVA genes, probably due to the low sample num-
ber, which was only ten for one gene. However, when all 
fifty RBS sequences were subjected to calculation, a logo 
with very high diversity was achieved (Additional file  2: 
Figure S1). In addition, among the fifty sequenced RBSs, 
ratio of the highest calculated RBS strength to the low-
est was 183,455/92 [25, 26], which indicated an expres-
sion dynamic range of about 2000-fold. The results proved 
that TRCM technique process did not create significant 
bias, and were able to generate quite diverse combinatory 
expression library.
An approximate expression pattern of optimal MVA 
pathway was illustrated
To illustrate a general and approximate expression pat-
tern of an efficient MVA pathway in E. coli cell factories, 
RBS strength of the MVA genes was analyzed with the 
RBS Calculator [25, 26]. Calculated RBS strength was 
represented by the translation initiation rate as listed in 
Table  2. The calculated RBS strength was by no means 
a very accurate measurement of the expression status of 
mvaE, mvaS, mvaK1, mvaD and mvaK2, however, could 
give a good estimation of a general trend of the optimized 
expression status of MVA pathway. For better illustration, 
the highest RBS strength for each gene was defined as 1, 
and a relative RBS strength of the ten strains for this gene 
was calculated accordingly (Fig.  5). The ten strains are 
lined up along the X axis according to their β-carotene 
yield. MVA gene expression pattern of ALV145 strain 
with the highest yield was obvious, that all genes were 
regulated to a medium level. In contrast, some of the 
inefficient strains had one or more MVA genes fell to 
very low expression level, or one or more genes reached 
the highest level. It was reported that some MVA path-
way intermediates were toxic, for example HMG-CoA, 
accumulation of which affected cell growth and pathway 
efficiency [4]. Besides, Mevalonate kinase (MK), encoded 
by mvaK1, was identified as a rate-limiting enzyme [21]. 
Thus in an optimized MVA pathway, mvaE should be 
coordinately expressed with mvaS to avoid HMG-CoA 
Fig. 4 β-carotene yield and cell mass of representative strains from the combinatory expression library DXS37-IDI46 (pACYC184-AL-mva). Strains 
include ALV104, ALV131, ALV100, ALV108, ALV20, ALV63, ALV25, ALV133, ALV23, ALV145 and parent strain DXS37-IDI46. Three repeats were per-
formed for each strain, and the error bars represented standard deviation
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accumulation, and a higher expression of mvaK1 is 
desired. It was found by the expression analysis, except 
ALV131, most of the inefficient strains did not follow 
these two rules.
Analysis of the representative strains indicated that an 
efficient MVA pathway contained genes expressed at a 
medium level, among which mvaE coordinately expresses 
with mvaS to avoid HMG-CoA accumulation, and a 
higher expression level of mvaK1 is beneficial.
Conclusion
A TRCM technique was designed and established in 
the research, which could be easily applied to various 
applications in terms of metabolic pathway regula-
tion and optimization. An optimized MVA pathway 
was constructed with TRCM to increase β-carotene 
yield of E. coli cell factory by twofold, and the optimal 
regulation pattern of MVA pathway was analyzed and 
illustrated.
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